Canada Gene Therapy Group

Reading time: 2 min
WhatsApp ↗
Brazil–Canada Scientific Cooperation · Gene Editing and Gene Therapy

Canada Gene Therapy Group

Translational Research in CRISPR/Cas9 and Genetic Diseases

Canada Gene Therapy Group — International Scientific CooperationCanada Gene Therapy Group — International Scientific Cooperation

THE Canada Gene Therapy Group (CGTG) represents the frontier of international scientific cooperation between Brazilian Charitable Association for the Support of Allergies (ABBAA)the Brazil Without Allergies Project and world-renowned researchers from Université Laval / Center de Recherche du CHU de Québec (Canada), under the scientific leadership of Prof. Dr. Jacques P. TremblayThe group investigates clinical applications of gene editing by CRISPR/Cas9, Prime EditingMolecular DNA surgery, correction of inborn errors of immunity, genetic dystrophies, and ultra-fast molecular diagnostic methods.

🤝 Directly support Professor Jacques P. Tremblay's gene therapy research at the Fondation du CHU de Québec →

✔ Medical and scientific content reviewed and validated. by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Clinical Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Lecture on Gene Therapy — Prof. Jacques P. Tremblay and Gabriel Lamothe (Université Laval)

Official Publications, Master Lectures and International Symposium on Gene Therapy

Explore below the digital books from the Brazil-Canada Chamber of Commerce (CCBC — Health Innovation Committee), the masterclasses on gene therapy at the Naval Academy and the Santa Casa da Misericórdia in Rio de Janeiro, the TEDx talk by Prof. Jacques P. Tremblay, and the national coverage in the scientific press:

Applications in Inborn Errors of Immunity, Rare Diseases, and Molecular Diagnostics

The advancement of genomic engineering tools derived from the bacterial system CRISPR transformed the therapeutic horizon of rare genetic diseases and of primary immunodeficiencies (inborn errors of immunity)While CRISPR/SHERLOCK-based diagnostic tests allow for the identification of viral nucleic acids hours after infection with very high sensitivity and low cost, the Prime Editing This research studies the precise correction of point mutations without deleterious double-strand breaks in the DNA strand. Check out the full collection of supplementary resources in our resource center. Continuing Medical Education.